Anne Y. Lai

2.1k total citations
20 papers, 1.4k citations indexed

About

Anne Y. Lai is a scholar working on Immunology, Molecular Biology and Oncology. According to data from OpenAlex, Anne Y. Lai has authored 20 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Immunology, 6 papers in Molecular Biology and 6 papers in Oncology. Recurrent topics in Anne Y. Lai's work include T-cell and B-cell Immunology (9 papers), Immune Cell Function and Interaction (7 papers) and Epigenetics and DNA Methylation (4 papers). Anne Y. Lai is often cited by papers focused on T-cell and B-cell Immunology (9 papers), Immune Cell Function and Interaction (7 papers) and Epigenetics and DNA Methylation (4 papers). Anne Y. Lai collaborates with scholars based in United States, Canada and Japan. Anne Y. Lai's co-authors include Motonari Kondo, Paul A. Wade, Kazu Kikuchi, Chia‐Lin Hsu, Yuan Zhuang, Simon Lin, David L. Jaye, Akiko Watanabe, Deepak Mav and Ruchir Shah and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Journal of Experimental Medicine and Nature reviews. Cancer.

In The Last Decade

Anne Y. Lai

19 papers receiving 1.4k citations

Peers

Countries citing papers authored by Anne Y. Lai

Since Specialization

Citations

This map shows the geographic impact of Anne Y. Lai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anne Y. Lai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anne Y. Lai more than expected).

Fields of papers citing papers by Anne Y. Lai

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anne Y. Lai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anne Y. Lai. The network helps show where Anne Y. Lai may publish in the future.

Co-authorship network of co-authors of Anne Y. Lai

This figure shows the co-authorship network connecting the top 25 collaborators of Anne Y. Lai. A scholar is included among the top collaborators of Anne Y. Lai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anne Y. Lai. Anne Y. Lai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Abstract 6722: A CD33 antigen targeted Gamma Delta T-cell engager in combination with zoledronate promotes Vg9Vd2+ T cell proliferation and cytotoxicity against acute myeloid leukemia 2024 ·Cancer Research ·Anne Y. Lai, Chunyan Wang, Dana C. Baiu, (unknown), Arpita Patel, (unknown), (unknown), Derek A. Franklin, Mahmud M. Hussain, J. L. Pate, (unknown), Vishruti Makani, Abhinav Shukla, Keith S. Wilson, George Fromm, Taylor H. Schreiber, Jenny E. Gumperz, Suresh de Silva	1
2	CDK4/6 inhibition enhances antitumor efficacy of chemotherapy and immune checkpoint inhibitor combinations in preclinical models and enhances T-cell activation in patients with SCLC receiving chemotherapy 2020 ·Journal for ImmunoTherapy of Cancer ·Anne Y. Lai, Jessica A. Sorrentino, Konstantin H. Dragnev, Jared Weiss, Taofeek K. Owonikoko, Julie Rytlewski, Jill Hood, Yang Zhao, Rajesh Malik, Jay C. Strum, Patrick J. Roberts	58
3	Abstract 1752: Transient exposure of trilaciclib, a CDK4/6 inhibitor, modulates gene expression in tumor immune infiltrates to promote a pro-inflammatory tumor microenvironment 2018 ·Cancer Research ·Anne Y. Lai, Jessica A. Sorrentino, Jay C. Strum, Patrick J. Roberts	3
4	Trilaciclib (trila) preserves and enhances immune system function in extensive-stage small cell lung cancer (ES-SCLC) patients receiving first-line chemotherapy 2018 ·Annals of Oncology ·(unknown), Anne Y. Lai, (unknown), Konstantin H. Dragnev, Taofeek K. Owonikoko, (unknown), Joyce Antal, Rajesh Malik, Patrick J. Roberts	0
5	Abstract 5628: Trilaciclib (G1T28), a CDK4/6 inhibitor, enhances the efficacy of combination chemotherapy and immune checkpoint inhibitor treatment in preclinical models 2017 ·Cancer Research ·Jessica A. Sorrentino, Anne Y. Lai, Jay C. Strum, Patrick J. Roberts	6
6	Inhibition of histone binding by supramolecular hosts 2014 ·Biochemical Journal ·(unknown), Kevin D. Daze, Takashi Shimbo, Anne Y. Lai, Catherine A. Musselman, Jennifer K. Sims, Paul A. Wade, Fraser Hof, Tatiana G. Kutateladze	37
7	The Satb1 Protein Directs Hematopoietic Stem Cell Differentiation toward Lymphoid Lineages 2013 ·Immunity ·Yusuke Satoh, Takafumi Yokota, Takao Sudo, Motonari Kondo, Anne Y. Lai, Paul W. Kincade, Taku Kouro, Ryuji Iida, Koichi Kokame, Toshiyuki Miyata, (unknown), (unknown), Hirokazu Tanaka, Itaru Matsumura, Kenji Oritani, Terumi Kohwi-shigematsu, Yuzuru Kanakura	85
8	Diethylstilbestrol (DES)-Stimulated Hormonal Toxicity is Mediated by ER α *Alteration of Target Gene Methylation Patterns and Epigenetic Modifiers ( DNMT3A* , MBD2 , and HDAC2 ) in the Mouse Seminal Vesicle** 2013 ·Environmental Health Perspectives ·Yin Li, Katherine J. Hamilton, Anne Y. Lai, Katherine A. Burns, Leping Li, Paul A. Wade, Kenneth S. Korach	38
9	DNA methylation profiling in human B cells reveals immune regulatory elements and epigenetic plasticity at Alu elements during B-cell activation 2013 ·Genome Research ·Anne Y. Lai, Deepak Mav, Ruchir Shah, Sara A. Grimm, Dhiral Phadke, Katerina Hatzi, Ari Melnick, Cissy Geigerman, (unknown), David L. Jaye, Paul A. Wade	85
10	Cancer biology and NuRD: a multifaceted chromatin remodelling complex 2011 ·Nature reviews. Cancer ·Anne Y. Lai, Paul A. Wade	379
11	DNA methylation prevents CTCF-mediated silencing of the oncogene BCL6 in B cell lymphomas 2010 ·The Journal of Experimental Medicine ·Anne Y. Lai, Mehrnaz Fatemi, Archana Dhasarathy, Christine C. Malone, (unknown), Cissy Geigerman, David L. Jaye, Deepak Mav, Ruchir Shah, Leping Li, Paul A. Wade	78
12	Pertussis toxin–sensitive G proteins regulate lymphoid lineage specification in multipotent hematopoietic progenitors 2009 ·Blood ·Anne Y. Lai, Akiko Watanabe, (unknown), Motonari Kondo	12
13	IL-7 Specifies B Cell Fate at the Common Lymphoid Progenitor to Pre-ProB Transition Stage by Maintaining Early B Cell Factor Expression 2008 ·The Journal of Immunology ·Kazu Kikuchi, Hirotake Kasai, Akiko Watanabe, Anne Y. Lai, Motonari Kondo	61
14	T and B lymphocyte differentiation from hematopoietic stem cell 2008 ·Seminars in Immunology ·Anne Y. Lai, Motonari Kondo	37
15	Identification of a bone marrow precursor of the earliest thymocytes in adult mouse 2007 ·Proceedings of the National Academy of Sciences ·Anne Y. Lai, Motonari Kondo	76
16	E2A and HEB Are Required to Block Thymocyte Proliferation Prior to Pre-TCR Expression 2007 ·The Journal of Immunology ·(unknown), Anne Y. Lai, Motonari Kondo, Yuan Zhuang	88
17	Asymmetrical lymphoid and myeloid lineage commitment in multipotent hematopoietic progenitors 2006 ·The Journal of Experimental Medicine ·Anne Y. Lai, Motonari Kondo	112
18	Antagonistic effect of CCAAT enhancer-binding protein-α and Pax5 in myeloid or lymphoid lineage choice in common lymphoid progenitors 2006 ·Proceedings of the National Academy of Sciences ·Chia‐Lin Hsu, Angela G. Fleischman, Anne Y. Lai, Yukie Matsumoto, Irving L. Weissman, Motonari Kondo	52
19	Heterogeneity of Flt3-Expressing Multipotent Progenitors in Mouse Bone Marrow 2005 ·The Journal of Immunology ·Anne Y. Lai, Simon Lin, Motonari Kondo	65
20	IL-7 receptor signaling is necessary for stage transition in adult B cell development through up-regulation of EBF 2005 ·The Journal of Experimental Medicine ·Kazu Kikuchi, Anne Y. Lai, Chia‐Lin Hsu, Motonari Kondo	174

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact